A Phase I/II Trial of HCB101 in Combination With Pembrolizumab for Patients With Platinum-Refractory, Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (SirH&N Trial)
Abroad (travel likely)RecruitingPHASE1, PHASE2
Conditions
HNSCC
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Chang-Gung Memorial Hospital(Lin-Kou), Taoyuan, Guishan District, Taiwan
Contact: Principal Investigator (Chia-Hsun Hsieh)National Taiwan University Hospital, Taipei, Taipei City, Taiwan
Contact: Principal Investigator (Huai-Cheng Huang)Taipei Veterans General Hospital, Taipei, Taipei City, Taiwan
Contact: Principal Investigator (Mu-Hsin Chang)
Study leads
Mu-Hsin Chang
Principal Investigator
Taipei Veterans General Hospital, Taiwan